Oncolytic Virus Therapy Market - Top Companies and Manufacturers

Companies Dominating the Oncolytic Virus Therapy Landscape

Amgen Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Shanghai Sunway Biotech Co. Ltd.
Oncolys BioPharma Inc.
TILT Biotherapeutics Ltd.
Oncorus Inc
TAKARA BIO INC.
Vyriad
Transgene SA
Lokon Pharma AB
Pfizer Inc.
Rigvir Group
Sibiono GeneTech Co. Ltd.
Oncolytics Biotech
Daiichi Sankyo
Kissei Pharmaceutical Co., Ltd.
Boehringer Ingelheim

Browse Key Market Insights with Data Illustration:

Oncolytic Virus Therapy Market Size & Share, Growth Outlook 2037

In the News

Daiichi Sankyo announced that it has received approval for its oncolytic virus G47 (trade name: DELYTACT). The approval is primarily based on the Japan Ph2 research (investigator led-study) findings led by Dr. Todo of the Institute of Medical Science, The University of Tokyo undertaken in patients with residual or recurrent glioblastoma.
TILT Biotherapeutics Ltd. partnered with Biotheus Inc. to promote the global development and marketing of TILT-123, a cancer treatment product, and also make it available to Chinese cancer patients. Further, the agreement involves a down payment as well as payments at specified points in the clinical research process and is qualified to collect large royalties on future sales payments.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of oncolytic virus therapy is evaluated at USD 27.99 million.

The oncolytic virus therapy market size was valued at USD 23.09 million in 2024 and is expected to reach USD 490.46 million by 2037, registering around 26.5% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of cancer globally and the growing advancements in viral engineering will drive the market growth.

North America industry is predicted to dominate majority revenue share of 39% by 2037, impelled by growing clinical activities in the region.

The major players in the market include Amgen Inc., Shanghai Sunway Biotech Co. Ltd., Oncolys BioPharma Inc., TILT Biotherapeutics Ltd., Oncorus Inc, TAKARA BIO INC., Vyriad, Transgene SA, Lokon Pharma AB, Pfizer, Inc., Rigvir Group, Sibiono GeneTech Co. Ltd., Oncolytics Biotech, Daiichi Sankyo, Kissei Pharmaceutical Co., Ltd., Boehringer Ingelheim

Oncolytic Virus Therapy Market - Top Companies and Manufacturers

Companies Dominating the Oncolytic Virus Therapy Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How much is the oncolytic virus therapy market worth?

Why is the demand for oncolytic virus therapy growing?

Which region dominated the majority of oncolytic virus therapy industry share?

Who are the top oncolytic virus therapy companies?